Mirum Pharmaceuticals, Inc.·4

Jan 27, 4:49 PM ET

BJERKHOLT ERIC 4

4 · Mirum Pharmaceuticals, Inc. · Filed Jan 27, 2025

Insider Transaction Report

Form 4
Period: 2025-01-23
BJERKHOLT ERIC
CHIEF FINANCIAL OFFICER
Transactions
  • Exercise/Conversion

    Common Stock

    2025-01-23+2,66735,946 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-01-232,6675,333 total
    Common Stock (2,667 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer).
  • [F2]1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date.

Documents

1 file
  • 4
    form4-01272025_090146.xmlPrimary